BCR and ovarian neoplasm: After performing a pathway enrichment analysis using Reactome39 we found that the 10 proteins specific to the ovarian tumour samples were immunoglobulins enriched in elements of the CD22 mediated BCR regulation pathway (Reactome pathway identifier R-HSA-5690714, FDR p-value = 2.89 E-15).